Treatment of Metastatic Pheochromocytoma With Streptozocin
- 1 September 1983
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 143 (9) , 1799-1800
- https://doi.org/10.1001/archinte.1983.00350090181033
Abstract
• A 58-year-old man who had a malignant pheochromocytoma with hepatic metastasis was treated with 2 g/mo of Intravenous streptozocin for 18 months. There was a reduction in his urinary excretion of dopamine (from 33,840 to 731 μg/24 hr), homovanillic acid (from 48 to 8 mg/24 hr), and vanillylmandelic acid (from 350 to 74 mg/24 hr). There also was a reduction in the size of his hepatic metastasis (50%) and a right adrenal mass (25%), as well as a marked clinical improvement in his condition. Based on this evidence, I believe further attempts to treat patients with metastatic pheochromocytoma with streptozocin seem warranted. (Arch Intern Med 1983;143:1799-1800)This publication has 5 references indexed in Scilit:
- Elevated platelet norepinephrine concentration in patients with pheochromocytomasClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Single isotope derivative (radioenzymatic) methods in the measurement of catecholaminesMetabolism, 1980
- One hundred cases of pheochromocytoma (107 tumors) at the columbia-presbyterian medical center, 1926-1976.A clinicopathological analysisCancer, 1977
- The neurocristopathiesA unifying concept of disease arising in neural crest maldevelopmentHuman Pathology, 1974
- Determination of 3-methoxy-4-hydroxymandelic acid in urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1962